Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroko Tanino is active.

Publication


Featured researches published by Hiroko Tanino.


Neuroscience Letters | 2001

Differential subcellular localization of caspase family proteins in the adult rat brain

Shun Shimohama; Hiroko Tanino; Sadaki Fujimoto

The distribution of the caspase family (caspase-2, -3, -6, -7, -8, -9, -10) was assessed using immunochemical detection of subcellular fractions of 8-week-old rat brain tissues. The present study demonstrated that the relative protein level of caspase-2, -3, -6, -8 and -10 was highest in the soluble cytosolic fraction, while that for caspase-9 was highest in the nucleus. We also found that caspase-3 and -6 were present at high levels and caspase-2, -8 and -9 at moderate levels in the nerve endings fraction as well as in the soluble cytosolic fraction. These results suggest that rat brain caspases are differentially expressed in the subcellular fractions of the rat brain, and that caspases not only contribute to the regulation of neuronal death, but also to synaptic plasticity.


Neuroscience Letters | 1998

Alteration of myo-inositol monophosphatase in Alzheimer's disease brains.

Shun Shimohama; Hiroko Tanino; Yasuo Sumida; Junji Tsuda; Sadaki Fujimoto

myo-Inositol monophosphatase (E.C.3.1.3.25) catalyzes the hydrolysis of myo-inositol 1-phosphate in the presence of Mg2+ at a physiologic pH to form free myo-inositol, maintaining a supply that represents the precursor for inositol phospholipid second messenger signaling systems. In the present study the activity and protein level of myo-inositol monophosphatase were investigated in samples from normal human and Alzheimers disease (AD) postmortem brains. The separation profile on Sephadex G-100 gel filtration chromatography revealed one major form of myo-inositol monophosphatase in crude extracts from both normal human and AD brains. In AD brains myo-inositol monophosphatase activity and its protein level were significantly higher than in control brains. The activity of myo-inositol monophosphatase per enzyme molecule was similar in control and AD brains. These results suggest that myo-inositol monophosphatase is upregulated in AD, probably reflecting compensatory mechanisms concerned with phospholipid metabolism.


Life Sciences | 2003

Effects of hyperoxia and acrylonitrile on the phospholipase C isozyme protein levels in rat heart and brain.

Kazuki Nagasawa; Hiroko Tanino; Shun Shimohama; Sadaki Fujimoto

We previously showed that hyperoxia exerts oxidative stress on the rat cerebral cortex, and the protein levels of phospholipase C (PLC) -beta1 and -delta1, but not PLC-gamma1, were changed. Acrylonitrile (ACN) appears to induce astrocytomas through induction of oxidative stress on the rat brain selectively. This study compared hyperoxia or ACN treatments of rats with respect to lipid peroxidation and PLC levels in the heart and cerebral cortex. Treatment of rats with ACN promoted lipid peroxidation in the heart and cerebral cortex, the percent increase above control being greater in the cortex than heart. Hyperoxia did not cause significant increases in lipid peroxidation in the cerebral cortex or heart. In the ACN-treated cerebral cortex, significant increases in the PLC-beta1 and -delta1 in the cytosol, and PLC-gamma1 in the cytosolic and particulate fractions, and lysate were observed. In the rat heart, in which PLC-beta1 could not be detected, PLC-gamma1 and -delta1 were increased and decreased in the cytosolic and particulate fractions, respectively, by hyperoxia. In addition, the expression level of PLC-gamma1 was decreased in the lysate by the treatment. In the heart treated with ACN, there was no change in the level of PLC-gamma1, while PLC-delta1 was elevated in all fractions. These findings suggested that the expression levels of PLC isozymes are altered by hyperoxia and ACN, but there are apparent differences in these altered levels between the different levels of oxidative stress, and between the organs.


General Pharmacology-the Vascular System | 1998

myo-Inositol Monophosphatase in the Brain Has Zinc Ion-Dependent Tyrosine Phosphatase Activity

Sadaki Fujimoto; Junji Tsuda; Naoko Kawakami; Hiroko Tanino; Shun Shimohama

1. myo-Inositol monophosphatase (E.C. 3.1.3.25) hydrolyzes inositol monophosphate to form free myo-inositol, the precursor for the inositol phospholipid second-messenger signaling systems. The biochemical properties of the enzyme were examined in detail. 2. The enzyme exhibited significant hydrolytic activity only on phosphotyrosine among physiological substrates tested in the presence of Zn2+ ions in an acidic environment. 3. The enzyme was recognized and immunoprecipitated with polyclonal antibodies developed against the Zn2+-dependent tyrosine phosphatase of bovine brain. 4. These results indicate that myo-inositol monophosphatase exhibits Zn2+-dependent tyrosine phosphatase activity in an acidic environment and has immunological identity with a Zn2+-dependent tyrosine phosphatase.


Biochemical and Biophysical Research Communications | 2000

Activation of NADPH oxidase in Alzheimer's disease brains.

Shun Shimohama; Hiroko Tanino; Naoko Kawakami; Naoki Okamura; Hiroomi Kodama; Teruhide Yamaguchi; Takao Hayakawa; Akihiko Nunomura; Shigeru Chiba; George Perry; Mark A. Smith; Sadaki Fujimoto


Biochemical and Biophysical Research Communications | 1999

CHANGES IN CASPASE EXPRESSION IN ALZHEIMER'S DISEASE : COMPARISON WITH DEVELOPMENT AND AGING

Shun Shimohama; Hiroko Tanino; Sadaki Fujimoto


Biochemical and Biophysical Research Communications | 1998

Differential Expression of Rat Brain Bcl-2 Family Proteins in Development and Aging ☆

Shun Shimohama; Sadaki Fujimoto; Yasuo Sumida; Hiroko Tanino


Biochemical and Biophysical Research Communications | 2001

Differential expression of rat brain caspase family proteins during development and aging.

Shun Shimohama; Hiroko Tanino; Sadaki Fujimoto


Biochemical and Biophysical Research Communications | 2000

Increase in Phospholipase C-δ1 Protein Levels in Aluminum-Treated Rat Brains

Hiroko Tanino; Shun Shimohama; Yoshinori Sasaki; Yasuo Sumida; Sadaki Fujimoto


Biological & Pharmaceutical Bulletin | 1999

Abundance of Low Molecular Weight Phosphotyrosine Protein Phosphatase in the Nerve-Ending Fraction in the Brain

Hiroko Tanino; Jun-ichi Yoshida; Ryoji Yamamoto; Yumi Kobayashi; Shun Shimohama; Sadaki Fujimoto

Collaboration


Dive into the Hiroko Tanino's collaboration.

Top Co-Authors

Avatar

Sadaki Fujimoto

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Shun Shimohama

Sapporo Medical University

View shared research outputs
Top Co-Authors

Avatar

Junji Tsuda

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Yasuo Sumida

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Kazuki Nagasawa

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar

Naoko Kawakami

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun-ichi Yoshida

Kyoto Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ryoji Yamamoto

Kyoto Pharmaceutical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge